Language: English
Gender: Male
WCM Physician (What is this?)
Solid Tumor Oncology
1305 York Avenue, 12th Floor
New York, NY 10021
P: 646-962-6200 | F: 212-746-8572
Call for appointment
646-962-6200

Personal Statement

I am a physician-scientist with a clinical focus on treating patients with advanced thyroid cancers. I completed training in Hematology and Medical Oncology at Dana Farber Cancer Institute and joined the faculty at Weill Cornell Medical College in 2011. To advance the care of patients with thyroid cancer around the world, I have been actively involved in an international cooperative thyroid cancer oncology group (ITOG). Additionally, I have participated in clinical trials for tyrosine kinase inhibitor (TKI) therapy for patients with advanced thyroid cancer. I am dedicated to cancer research in order to lead us one step closer to a cure. I am particularly interested in cancer genetics in order to identify personalized therapies to fight cancer based on the genetic profiles of an individual’s tumors. I also lead a cancer genetics lab at Weill Cornell where we use a model organism, zebrafish, to identify new drugs and drug targets.

View Biography

Specialties/Expertise

Board Certifications
  • Internal Medicine
  • Medical Oncology
Specialties
  • Medical Oncology
Expertise
  • Thyroid Cancer
  • Recurrent Thyroid Cancer
  • Metastasis from Thyroid Cancer
  • Anaplastic Thyroid Carcinoma
  • Thyroid Cancer, Medullary Carcinoma
  • Medullary Thyroid Carcinoma
  • Thyroid Ca
  • Cancer of Thyroid Gland
  • Thyroid Carcinoma
  • Anaplastic Carcinoma of Thyroid
  • Medullary Carcinoma of Thyroid
  • Primary Thyroid Cancer

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA [PPO]
  • AETNA [Medicare]
  • AETNA [HMO]
  • Aetna - Weill Cornell [POS]
  • Affinity Access
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Empire Blue Cross/Blue Shield HealthPlus
  • Empire Empire Blue Cross/Blue Shield HealthPlus [CHP]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP)
  • Medicaid
  • Medicare
  • Oxford Health Plans [Metro/Core/Charter]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Freedom]
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • United Health Care
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]
  • VNSNY CHOICE Medicare [Medicare]

Education/Training

  • M.D., Mount Sinai School of Medicine, 2001
  • Ph.D., Mount Sinai School of Medicine, 2000
  • B.S., University of Michigan, 1992

Biography

Titles

Assistant Professor of Medicine in Surgery
Weill Cornell Medical College

Assistant Attending Physician
NewYork-Presbyterian Hospital

Assistant Professor of Cell and Developmental Biology
Weill Cornell Medical College, Cornell University

Assistant Professor of Medicine
Weill Cornell Medical College, Cornell University

Biography

PROFESSIONAL TRAINING:

Intern, Internal Medicine, Massachusetts General Hospital, 2001-02

Resident, Internal Medicine, Massachusetts General Hospital, 2002-03

Fellow, Hematology-Oncology, Dana Farber Cancer Institute, 2003-08

Research Fellow, Boston Children’s Hospital, Leonard Zon Laboratory, 2005-10

 

Dr. Yariv Houvras is an internationally-renowned expert in the treatment and care of patients with advanced thyroid cancers, including differentiated thyroid cancer, papillary and follicular cancers, poorly differentiated, anaplastic and medullary thyroid cancers. Dr. Houvras is a physician-scientist with an active laboratory program to explore the genetic basis of tumor initiation and progression.

Dr. Houvras leads a laboratory program utilizing zebrafish, a small freshwater fish, amenable to genetic studies. Work in the Houvras lab has led to new personalized models of cancer. These models are being tested to identify new treatments for patients with cancer. The zebrafish are also being used in drug discovery efforts to identify new inhibitors of cancer growth and metastasis.

Dr. Houvras was recruited to Weill Cornell Medical College in 2011 and has served as Assistant Professor of Medicine in the Departments of Surgery and Medicine. He is a member of the Meyer Cancer Center and Cancer Genetics and Epigenetics Working Group. Dr. Houvras is the recipient of numerous awards and grants, including a K08 mentored physician-scientist award, an R21 from the NIH, and a tri-institutional drug discovery award to develop novel epigenetic inhibitors for cancer. He also serves on the board of the International Thyroid Oncology Group (ITOG), an interdisciplinary organization that coordinates clinical trials and translational studies in thyroid cancer.

Dr. Houvras is a graduate of the University of Michigan (B.S. in Biology, 1992) and the MSTP program at Mount Sinai School of Medicine where he earned a combined MD/PhD degree (2001). Dr. Houvras was an intern and resident at Massachusetts General Hospital (MGH), and a fellow in Hematology-Oncology at the combined Dana-Farber/MGH program. He completed post-doctoral studies in cancer genetics at Boston Children's Hospital. He was recruited to Weill Cornell Medicine and NewYork-Presbyterian Hospital in 2011.